Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 29 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Keyword is Risk Reduction Behavior [Clear All Filters]
Dietary patterns and cardiovascular disease in Greek adults: The Hellenic National Nutrition and Health Survey (HNNHS)..
Nutr Metab Cardiovasc Dis. 30(2), 201-213.
(2020).
(2020).
(2019).
(2019).
Comparison Among Recommendations for the Management of Arterial Hypertension Issued by Last US, Canadian, British and European Guidelines..
High Blood Press Cardiovasc Prev. 25(1), 9-16.
(2018).
(2018). Current and future treatment options in non-alcoholic steatohepatitis (NASH)..
Expert Rev Gastroenterol Hepatol. 11(4), 357-369.
(2017). Liver Transplantation in the Obese Cirrhotic Patient..
Transplantation. 101(10), 2288-2296.
(2017). Exploring the Management of Statin Intolerant Patients: 2016 and Beyond..
Curr Vasc Pharmacol. 14(6), 523-533.
(2016). Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update..
World J Gastroenterol. 21(22), 6820-34.
(2015). Effects of acute and chronic exercise in patients with essential hypertension: benefits and risks..
Am J Hypertens. 28(4), 429-39.
(2015). Health benefits of the Mediterranean Diet: an update of research over the last 5 years..
Angiology. 66(4), 304-18.
(2015). Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk..
Expert Opin Drug Saf. 14(7), 1035-53.
(2015). How to treat erectile dysfunction in men with diabetes: from pathophysiology to treatment..
Curr Diab Rep. 14(11), 545.
(2014). Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients..
Curr Med Res Opin. 29(7), 791-2.
(2013). Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis..
Angiology. 63(5), 358-66.
(2012). Pharmacotherapy: statins and new-onset diabetes mellitus--a matter for debate..
Nat Rev Endocrinol. 8(3), 133-4.
(2012). Health promotion as a behavioural challenge: are we missing attitudes?.
Glob Health Promot. 18(2), 54-7.
(2011). Residual cardiac risk reduction beyond lipid lowering..
Hellenic J Cardiol. 52(3), 197-203.
(2011). Chronic venous disease progression and modification of predisposing factors..
J Vasc Surg. 51(4), 900-7.
(2010). Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management..
Nutr Metab Cardiovasc Dis. 20(2), 140-6.
(2010). Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?.
Curr Pharm Des. 16(34), 3939-847.
(2010).
(2010). Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED study..
Curr Med Res Opin. 25(8), 1931-40.
(2009). Psychotherapeutic intervention and suicide risk reduction in bipolar disorder: a review of the evidence..
J Affect Disord. 113(1-2), 21-9.
(2009).